Related Experiment Video

Updated: Jun 28, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
08:17

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

Neurolological disorders and neuroprotection after heart surgery

Georgios I Tagarakis1

  • 1Cardiothoracic Department, University Hospital of Larissa, Greece. gtagarakis@hotmail.com

Recent Patents on CNS Drug Discovery
|November 11, 2008
PubMed

Insights

This review explores genetic factors contributing to neurological complications after heart surgery, such as cognitive decline and delirium. It also discusses potential pharmacological treatments for these conditions.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Background:

  • Neurological and neuropsychiatric complications frequently occur following cardiac surgery.
  • These complications include cerebral ischemic episodes, transient ischemic attacks, postoperative cognitive decline, and postoperative delirium.

Purpose of the Study:

  • To review the etiology of post-cardiac surgery neurological complications.
  • To emphasize the role of genetic components in the development of these complications.
  • To discuss the potential use of pharmacological agents in managing these neurological and neuropsychiatric conditions.

Main Methods:

  • Literature review focusing on etiology and genetic factors.
  • Analysis of existing research on neurological complications post-heart surgery.
  • Examination of pharmacological interventions for relevant conditions.

Main Results:

  • Genetic factors are implicated in the etiology of various neurological complications after heart surgery.
  • Specific genetic components may predispose individuals to conditions like postoperative cognitive decline and delirium.
  • Pharmacological agents show potential in treating these neurological sequelae.

Conclusions:

  • Understanding the genetic underpinnings of post-cardiac surgery neurological complications is crucial.
  • Targeting genetic predispositions may offer novel therapeutic strategies.
  • Pharmacological interventions warrant further investigation for effective management.

More Related Videos

Spinal Cord Neurons Isolation and Culture from Neonatal Mice07:49

Spinal Cord Neurons Isolation and Culture from Neonatal Mice

Published on: July 11, 2017

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...